13087 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Levine
    Levine
  4. Zelenetz
    Zelenetz
  5. Horwitz
    Horwitz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Scheinberg
    Scheinberg
  8. Jakubowski
    Jakubowski
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)
  7. Lymphoma (2639)
  8. Sloan Kettering Institute Faculty (2602)
  9. Executive Committee, Center for Hematologic Malignancies (2358)
  10. Survivorship Research (2328)
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostication of older Hodgkin lymphoma (HL) patients (pts): Findings from a multicenter phase II study
    Meeting Abstract

    Evens, A. M.; Advani, R. H.; Fanale, M. A.; Smith, S. M.; Helenowski, I. B.; Bociek, G.; Klein, A. K.; Winter, J. N.; Gordon, L. I.; Hamlin, P. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia
    Meeting Abstract

    Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; Garcia-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Palomba, M. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia in the BFORE trial: 24-month follow-up
    Meeting Abstract

    Cortes, J. E.; Mauro, M. J.; Deininger, M. W. N.; Chuah, C.; Kim, D. W.; Kota, V.; Lipton, J. H.; Rousselot, P. H.; Milojkovic, D.; Le Coutre, P. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Cornell, R. F.; Locke, F. L.; Bishop, M. R.; Orlowski, R. Z.; Larson, S. M.; Borrello, I.; Giralt, S.; Kumar, S.; Nooka, A. K.; Raje, N. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired commercial next-generation sequencing assays
    Meeting Abstract

    Coombs, C. C.; Gillis, N.; Bolton, K. L.; Berg, J. S.; Tan, X.; Hayward, M. C.; Patel, N. M.; Ball, M.; Balasis, M.; Mesa, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    Bullement, A.; D'Angelo, S. P.; Amin, A.; Stapelkamp, C.; Willis, A.; Lilley, C.; Hatswell, A.; Bharmal, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study
    Meeting Abstract

    Biran, N.; Di Capua Siegel, D. S.; Berdeja, J. G.; Raje, N. S.; Cornell, R. F.; Alsina, M.; Kovacsovics, T.; Fang, B.; Kimball, A.; Landgren, C. O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tolerability and response of the novel SYK/JAK inhibitor cerdulatinib in a phase 2a study in relapsed/refractory peripheral T cell lymphoma (PTCL)
    Meeting Abstract

    Horwitz, S. M.; Hamlin, P. A.; Feldman, T.; Hess, B. T.; Mato, A. R.; Munoz, J.; Patel, M. R.; Ye, J. C.; Steele, A.; Pandey, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save